311 related articles for article (PubMed ID: 12905485)
1. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
Stone JH;
Arthritis Rheum; 2003 Aug; 48(8):2299-309. PubMed ID: 12905485
[TBL] [Abstract][Full Text] [Related]
2. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
[TBL] [Abstract][Full Text] [Related]
3. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
Stone JH; Holbrook JT; Marriott MA; Tibbs AK; Sejismundo LP; Min YI; Specks U; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune WJ; Ytterberg SR; Allen NB; Hoffman GS;
Arthritis Rheum; 2006 May; 54(5):1608-18. PubMed ID: 16646004
[TBL] [Abstract][Full Text] [Related]
4. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
Stone JH; Uhlfelder ML; Hellmann DB; Crook S; Bedocs NM; Hoffman GS
Arthritis Rheum; 2001 May; 44(5):1149-54. PubMed ID: 11352248
[TBL] [Abstract][Full Text] [Related]
5. Etanercept plus standard therapy for Wegener's granulomatosis.
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
[TBL] [Abstract][Full Text] [Related]
6. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s.
Abdou NI; Kullman GJ; Hoffman GS; Sharp GC; Specks U; McDonald T; Garrity J; Goeken JA; Allen NB
J Rheumatol; 2002 Feb; 29(2):309-16. PubMed ID: 11838848
[TBL] [Abstract][Full Text] [Related]
7. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
Finkielman JD; Lee AS; Hummel AM; Viss MA; Jacob GL; Homburger HA; Peikert T; Hoffman GS; Merkel PA; Spiera R; St Clair EW; Davis JC; McCune WJ; Tibbs AK; Ytterberg SR; Stone JH; Specks U;
Am J Med; 2007 Jul; 120(7):643.e9-14. PubMed ID: 17602941
[TBL] [Abstract][Full Text] [Related]
8. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
Koldingsnes W; Nossent JC
J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
[TBL] [Abstract][Full Text] [Related]
9. Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis.
Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gutfleisch J; Peter HH; Raspe HH; Gross WL
Arthritis Rheum; 2002 Jun; 47(3):320-5. PubMed ID: 12115163
[TBL] [Abstract][Full Text] [Related]
10. A brief history of Wegener's granulomatosis: on limited, localized, and generalized forms of the disease: comment on the article by the Wegener's Granulomatosis Etanercept Trial Research Group.
Lamprecht P; Gross WL
Arthritis Rheum; 2004 Jan; 50(1):334-5; author reply 335-6. PubMed ID: 14730635
[No Abstract] [Full Text] [Related]
11. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors.
Wung PK; Holbrook JT; Hoffman GS; Tibbs AK; Specks U; Min YI; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune J; Ytterberg SR; Allen NB; Stone JH;
Am J Med; 2005 Dec; 118(12):1416. PubMed ID: 16378799
[TBL] [Abstract][Full Text] [Related]
12. Difficulty of diagnosing Wegener's granulomatosis in the head and neck region.
Tsuzuki K; Fukazawa K; Takebayashi H; Hashimoto K; Sakagami M
Auris Nasus Larynx; 2009 Feb; 36(1):64-70. PubMed ID: 18479857
[TBL] [Abstract][Full Text] [Related]
13. Wegener's granulomatosis in patients with rheumatoid arthritis.
Douglas G; Bird K; Flume P; Silver R; Bolster M
J Rheumatol; 2003 Sep; 30(9):2064-9. PubMed ID: 12966617
[TBL] [Abstract][Full Text] [Related]
14. Predictors of damage and survival in patients with Wegener's granulomatosis: analysis of 50 patients.
Kamali S; Erer B; Artim-Esen B; Gul A; Ocal L; Konice M; Aral O; Inanc M
J Rheumatol; 2010 Feb; 37(2):374-8. PubMed ID: 20008921
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
Seo P; Specks U; Keogh KA
J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
[TBL] [Abstract][Full Text] [Related]
16. Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?
Holle JU; Gross WL; Holl-Ulrich K; Ambrosch P; Noelle B; Both M; Csernok E; Moosig F; Schinke S; Reinhold-Keller E
Ann Rheum Dis; 2010 Nov; 69(11):1934-9. PubMed ID: 20511614
[TBL] [Abstract][Full Text] [Related]
17. A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis.
Stone JH; Rajapakse VN; Hoffman GS; Specks U; Merkel PA; Spiera RF; Davis JC; St Clair EW; McCune J; Ross S; Hitt BA; Veenstra TD; Conrads TP; Liotta LA; Petricoin EF;
Arthritis Rheum; 2005 Mar; 52(3):902-10. PubMed ID: 15751091
[TBL] [Abstract][Full Text] [Related]
18. Wegener's granulomatosis--clinical analysis of 18 patients group.
Dabrowski A; Droszcz W
Med Sci Monit; 2000; 6(1):151-7. PubMed ID: 11208304
[TBL] [Abstract][Full Text] [Related]
19. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.
Stegeman CA; Tervaert JW; de Jong PE; Kallenberg CG
N Engl J Med; 1996 Jul; 335(1):16-20. PubMed ID: 8637536
[TBL] [Abstract][Full Text] [Related]
20. Limited utility of rapamycin in severe, refractory Wegener's granulomatosis.
Koening CL; Hernández-RodrÃguez J; Molloy ES; Clark TM; Hoffman GS
J Rheumatol; 2009 Jan; 36(1):116-9. PubMed ID: 19012360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
